| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.180.9.6411 |
| P8608 | Fatcat ID | release_ccxaqofzy5ae5dzfdnjpp7thdm |
| P698 | PubMed publication ID | 18424765 |
| P5875 | ResearchGate publication ID | 5427548 |
| P50 | author | Koen Venken | Q79782802 |
| P2093 | author name string | Piet Stinissen | |
| Karen Hensen | |||
| Jean-Luc Rummens | |||
| Niels Hellings | |||
| Tom Broekmans | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 6411-6420 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression | |
| P478 | volume | 180 |
| Q33528981 | A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells |
| Q64992762 | Alemtuzumab in Multiple Sclerosis: Short- and Long-Term Effects of Immunodepletion on the Peripheral Treg Compartment. |
| Q28080791 | Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases |
| Q95840980 | B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers |
| Q40963680 | Bovine γδ T cells are a major regulatory T cell subset. |
| Q35742931 | CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis |
| Q35178495 | CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game |
| Q53249924 | Central inflammation versus peripheral regulation in multiple sclerosis. |
| Q59149657 | Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors |
| Q49165904 | Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis |
| Q30242026 | Circulating immune cells in multiple sclerosis. |
| Q90690744 | Clinical and immunological features of severe and moderate coronavirus disease 2019 |
| Q47121013 | Clinical significance of circulating immune cells in left- and right-sided colon cancer |
| Q37272089 | Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored? |
| Q34217788 | DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients |
| Q38703915 | Deficiency of Phosphatidylinositol 3-Kinase δ Signaling Leads to Diminished Numbers of Regulatory T Cells and Increased Neutrophil Activity Resulting in Mortality Due to Endotoxic Shock |
| Q33625425 | Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells. |
| Q51886735 | Distributional characteristics of CD25 and CD127 on CD4+ T cell subsets in chronic HCV infection. |
| Q47101639 | Downregulation of cathepsin G reduces the activation of CD4+ T cells in murine autoimmune diabetes |
| Q33934466 | Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis |
| Q37551687 | Effects of multiple-dose ponesimod, a selective S1P1 receptor modulator, on lymphocyte subsets in healthy humans |
| Q48298006 | Enrichment of Human CCR6+ Regulatory T Cells with Superior Suppressive Activity in Oral Cancer. |
| Q38272139 | Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine |
| Q35252405 | Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region. |
| Q34643537 | FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis |
| Q39018591 | Foxp3, Regulatory T Cell, and Autoimmune Diseases |
| Q39829102 | Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus |
| Q34388690 | Functional improvement of regulatory T cells from rheumatoid arthritis subjects induced by capsular polysaccharide glucuronoxylomannogalactan. |
| Q45135279 | Gene expression analysis reveals functional pathways of glatiramer acetate activation. |
| Q37732340 | Glatiramer acetate and the glatiramoid class of immunomodulator drugs in multiple sclerosis: an update |
| Q51738569 | Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. |
| Q26863405 | Gut commensalism, cytokines, and central nervous system demyelination |
| Q82498114 | Haplotype 4 of the multiple sclerosis-associated interleukin-7 receptor alpha gene influences the frequency of recent thymic emigrants |
| Q41295973 | Heterogeneity in multiple sclerosis: scratching the surface of a complex disease. |
| Q37410551 | IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients |
| Q28534445 | IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent |
| Q33433145 | Imbalanced immune homeostasis in immune thrombocytopenia |
| Q89943358 | Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy |
| Q93047730 | Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue |
| Q89036570 | Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis |
| Q63285399 | Immunopathology of multiple sclerosis |
| Q90089343 | Impact of treatment on cellular immunophenotype in MS: A cross-sectional study |
| Q34026055 | Impaired thymic export and apoptosis contribute to regulatory T-cell defects in patients with chronic heart failure |
| Q44982658 | In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling |
| Q36083062 | Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis |
| Q36994057 | Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis |
| Q37982378 | Inflammation and adaptive immunity in Parkinson's disease |
| Q36246917 | Interleukin-2 receptor-α proximal promoter hypomethylation is associated with multiple sclerosis |
| Q41869890 | Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients. |
| Q28741374 | Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE |
| Q36095922 | Mechanisms of immunological tolerance in central nervous system inflammatory demyelination |
| Q34615216 | Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases |
| Q40474467 | Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease. |
| Q59800414 | Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study |
| Q91740193 | Modulation of regulatory T cell function and stability by co-inhibitory receptors |
| Q50982903 | Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy. |
| Q28086853 | Multiple Sclerosis and T Lymphocytes: An Entangled Story |
| Q38760373 | Multiple sclerosis: a disorder of altered T-cell homeostasis |
| Q46816215 | Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis |
| Q37124529 | Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis |
| Q33713942 | Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis |
| Q38655679 | Oxidative stress in multiple sclerosis: Central and peripheral mode of action |
| Q42418046 | Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis |
| Q33650505 | Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation |
| Q36800150 | Phenotypic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg Cells in Patients With Chronic Rheumatoid Arthritis |
| Q36206608 | Predictors of immunosuppressive regulatory T lymphocytes in healthy women |
| Q82761026 | Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs |
| Q39302587 | Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation. |
| Q52624498 | Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant. |
| Q47195561 | Regulatory T Cells: From Discovery to Autoimmunity |
| Q48668293 | Regulatory T Cells: Molecular and Cellular Basis for Immunoregulation |
| Q38943933 | Regulatory T cell-based therapies for autoimmunity |
| Q82609485 | Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis |
| Q26825063 | Regulatory T cells in autoimmune neuroinflammation |
| Q38161354 | Regulatory T cells in colorectal cancer: from biology to prognostic relevance |
| Q38020963 | Regulatory T cells in the central nervous system |
| Q37834024 | Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis |
| Q37053851 | Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination |
| Q37997322 | Self-tolerance in multiple sclerosis |
| Q88543531 | Serotonin decreases the production of Th1/Th17 cytokines and elevates the frequency of regulatory CD4+ T-cell subsets in multiple sclerosis patients |
| Q59356059 | Small GTPase RAS in multiple sclerosis - exploring the role of RAS GTPase in the etiology of multiple sclerosis |
| Q36890946 | Specific peripheral B cell tolerance defects in patients with multiple sclerosis |
| Q42907197 | Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study |
| Q53331257 | T regulatory cells lacking CD25 are increased in MS during relapse. |
| Q92511375 | Targeting Phosphodiesterases-Towards a Tailor-Made Approach in Multiple Sclerosis Treatment |
| Q39148230 | Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments |
| Q92885753 | The Characterization of Regulatory T-Cell Profiles in Alzheimer's Disease and Multiple Sclerosis |
| Q50026939 | The Evolving Mechanisms of Action of Glatiramer Acetate |
| Q55003332 | The Footprints of Poly-Autoimmunity: Evidence for Common Biological Factors Involved in Multiple Sclerosis and Hashimoto's Thyroiditis. |
| Q58704148 | The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue |
| Q52603681 | The Role for Exosomal microRNAs in Disruption of Regulatory T Cell Homeostasis in Multiple Sclerosis. |
| Q37994432 | The human IL-7 receptor gene: deletions, polymorphisms and mutations. |
| Q51021263 | The interleukin-7 receptor α chain contributes to altered homeostasis of regulatory T cells in multiple sclerosis. |
| Q38172891 | The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. |
| Q37199648 | The role of regulatory T cells in multiple sclerosis |
| Q38035240 | The role of regulatory T cells in neurodegenerative diseases |
| Q93209101 | The role of thymic tolerance in CNS autoimmune disease |
| Q37012666 | Thymic hyperplasia after chemotherapy in adults with mature B cell lymphoma and its influence on thymic output and CD4(+) T cells repopulation |
| Q28081150 | Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease |
| Q90134973 | When encephalitogenic T cells collaborate with microglia in multiple sclerosis |
| Q41091710 | Zinc supplementation induces regulatory T cells by inhibition of Sirt-1 deacetylase in mixed lymphocyte cultures. |
| Q42344657 | miRNAs in multiple sclerosis: Regulating the regulators |
Search more.